Head-To-Head Review: DIAGNOS (OTCMKTS:DGNOF) versus Waystar (NASDAQ:WAY)

Waystar (NASDAQ:WAY) and DIAGNOS (OTCMKTS:DGNOF) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, institutional ownership, analyst recommendations and profitability.

Profitability

This table compares Waystar and DIAGNOS’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Waystar	11.18%	7.03%	4.75%
DIAGNOS	-7,014.89%	N/A	-192.10%

Risk & Volatility

Waystar has a beta of 0.08, meaning that its share price is 92% less volatile than the S&P 500. Comparatively, DIAGNOS has a beta of -0.09, meaning that its share price is 109% less volatile than the S&P 500.

Valuation & Earnings

This table compares Waystar and DIAGNOS”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waystar	$1.10 billion	3.68	$112.09 million	$0.70	30.16
DIAGNOS	$50,000.00	474.48	-$3.30 million	($0.04)	-4.90

Waystar has higher revenue and earnings than DIAGNOS. DIAGNOS is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Waystar and DIAGNOS, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waystar	1	2	18	3	2.96
DIAGNOS	0	0	0	0	0.00

Waystar presently has a consensus target price of $35.14, indicating a potential upside of 66.44%. Given Waystar’s stronger consensus rating and higher probable upside, equities research analysts clearly believe Waystar is more favorable than DIAGNOS.

Summary

Waystar beats DIAGNOS on 12 of the 13 factors compared between the two stocks.

About Waystar

Waystar Holding Corp. is a software company which provide healthcare payments. Waystar Holding Corp. is based in LEHI, Utah.

About DIAGNOS

DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.